Short-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections

Trends in Microbiology

Volumn 25, Issue 5, 2017, Pages 336-348

  Lythgoe, Katrina A ^a   Gardner, Andy ^b   Pybus, Oliver G ^a   Grove, Joe ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

evolution; transmission; virus

Indexed keywords

CHRONIC HEPATITIS; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NATURAL SELECTION; REVIEW; VIRUS REPLICATION; VIRUS TRANSMISSION; CHRONIC DISEASE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MOLECULAR EVOLUTION; MUTATION RATE; TRANSMISSION; VIROLOGY; VIRUS; VIRUS INFECTION;

CHRONIC DISEASE; EVOLUTION, MOLECULAR; HOST-PATHOGEN INTERACTIONS; HUMANS; MUTATION RATE; VIRUS DISEASES; VIRUSES;

EID: 85016488461     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2017.03.003     Document Type: Review

References (95)

1. 1 Foster, T.L., et al. Resistance of transmitted founder HIV-1 to IFITM-mediated restriction. Cell Host Microbe 4 (2016), 429–442.
2. 2 Murphy, M.K., et al. Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth. PLoS Pathog., 9, 2013, e1003173.
3. 3 Asquith, B., et al. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol., 4, 2006, e90.
4. 4 Goonetilleke, N., et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206 (2009), 1253–1272.
5. 5 Herbeck, J.T., et al. Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J. Virol. 85 (2011), 7523–7534.
6. 6 Leviyang, S., Ganusov, V.V., Broad CTL response in early HIV infection drives multiple concurrent CTL escapes. PLoS Comput. Biol. 11 (2015), 1–21.
7. 7 Petrovic, D., et al. Hepatitis C virus – T-cell responses and viral escape mutations. Eur. J. Immunol. 42 (2012), 17–26.
8. 8 Bull, R.A., et al. Transmitted/founder viruses rapidly escape from CD8(+) T cell responses in acute hepatitis C virus infection. J. Virol. 89 (2015), 5478–5490.
9. 9 Kouyos, R.D., et al. Assessing predicted HIV-1 replicative capacity in a clinical setting. PLoS Pathog., 7, 2011, e1002321.
10. 10 Deymier, M.J., et al. Heterosexual transmission of subtype C HIV-1 selects consensus-like variants without increased replicative capacity or interferon-α resistance. PLoS Pathog. 11 (2015), 1–22.
11. 11 Honegger, J.R., et al. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat. Med. 19 (2013), 1529–1533.
12. 12 Levin, B.R., Bull, J.J., Short-sighted evolution and the virulence of pathogenic microorganisms. Trends Microbiol. 2 (1994), 76–81.
13. 13 Duffy, S., et al. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 9 (2008), 267–276.
14. 14 Swanstrom, R., Coffin, J., HIV-1 pathogenesis: the virus. Cold Spring Harb. Perspect. Med., 2, 2012, a007443.
15. 15 Chalmet, K., et al. Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission. J. Infect. Dis. 205 (2012), 174–184.
16. 16 Frange, P., et al. Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner. PLoS One, 8, 2013, e69144.
17. 17 Joseph, S.B., et al. Bottlenecks in HIV-1 transmission: insights from the study of founder viruses. Nat. Rev. Microbiol. 13 (2015), 414–425.
18. 18 Wei, X., et al. Antibody neutralization and escape by HIV-1. Nature 422 (2003), 307–312.
19. 19 Iyer, S.S., et al. Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness. Proc. Natl. Acad. Sci. U.S.A. 114 (2017), E590–E599.
20. 20 Mason, W.S., et al. Immune selection during chronic hepadnavirus infection. Hepatol. Int. 2 (2008), 3–16.
21. 21 Frelin, L., et al. A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection. J. Virol. 83 (2009), 1379–1392.
22. 22 Kramvis, A., The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. Rev. Med. Virol. 26 (2016), 285–303.
23. 23 Chen, H., et al. Woodchuck hepatitis. J. Virol. 66 (1992), 5682–5684.
24. 24 Tong, S., Revill, P., Overview of hepatitis B viral replication and genetic variability. J. Hepatol. 64 (2016), S4–S16.
25. 25 Seki, S., Matano, T., CTL escape and viral fitness in HIV/SIV infection. Front. Microbiol. 2 (2012), 1–5.
26. 26 Kwei, K., et al. Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutation. J. Virol. 87 (2013), 2352–2357.
27. 27 Uebelhoer, L., et al. Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog. 4 (2008), 1–15.
28. 28 Carlson, J.M., et al. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science, 345, 2014, 1254031.
29. 29 Leslie, A.J., et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10 (2004), 282–289.
30. 30 Kawashima, Y., et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458 (2009), 641–645.
31. 31 Bedford, T., Malik, H.S., Did a single amino acid change make Ebola virus more virulent?. Cell 167 (2016), 892–894.
32. 32 Lackner, T., et al. Persistence of bovine viral diarrhea virus is determined by a cellular cofactor of a viral autoprotease. J. Virol. 79 (2005), 9746–9755.
33. 33 Lackner, T., et al. Dissection of a viral autoprotease elucidates a function of a cellular chaperone in proteolysis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 1510–1515.
34. 34 Peterhans, E., et al. Cytopathic bovine viral diarrhea viruses (BVDV): emerging pestiviruses doomed to extinction. Vet. Res. 41 (2010), 41–44.
35. 35 Bank-Wolf, B.R., et al. Mutations of 3c and spike protein genes correlate with the occurrence of feline infectious peritonitis. Vet. Microbiol. 173 (2014), 177–188.
36. 36 Borschensky, C.M.M., Reinacher, M., Mutations in the 3c and 7b genes of feline coronavirus in spontaneously affected FIP cats. Res. Vet. Sci. 97 (2014), 333–340.
37. 37 Kipar, A., Meli, M.L., Feline infectious peritonitis: still an enigma?. Vet. Pathol. 51 (2014), 505–526.
38. 38 Quinones-Mateu, M.E., A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J. Virol. 74 (2000), 9222–9233.
39. 39 Prince, J.L., et al. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS Pathog., 8, 2012, e1003041.
40. 40 Mellors, J.W., et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 (1996), 1167–1170.
41. + T-cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS 11 (1997), 1799–1806.
42. 42 Fraser, C., et al. Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 17441–17446.
43. 43 Lythgoe, K.A. et al. (2013) Is HIV short-sighted? Insights from a multistrain nested model. Evolution (N.Y.) 67, 2769–2782.
44. 44 Lemey, P., et al. HIV evolutionary dynamics within and among hosts. AIDS Rev. 8 (2006), 125–140.
45. 45 Pybus, O.G., Rambaut, A., Evolutionary analysis of the dynamics of viral infectious disease. Nat. Rev. Genet. 10 (2009), 540–550.
46. 46 Alizon, S., Fraser, C., Within-host and between-host evolutionary rates across the HIV-1 genome. Retrovirology 10 (2013), 49–58.
47. 47 Van Dooren, S., et al. The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains. Mol. Biol. Evol. 21 (2004), 603–611.
48. 48 Cook, L.B., et al. HTLV-1: persistence and pathogenesis. Virology 435 (2013), 131–140.
49. 49 Nowak, M.A., et al. Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 4398–4402.
50. 50 Summers, J., et al. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64 (1990), 2819–2824.
51. 51 Nassal, M., HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 64 (2015), 1972–1984.
52. 52 Harrison, A., et al. Genomic analysis of hepatitis B virus reveals antigen state and genotype as sources of evolutionary rate variation. Viruses 3 (2011), 83–101.
53. 53 Raghwani, J., et al. Exceptional heterogeneity in viral evolutionary dynamics characterises chronic hepatitis C virus infection. PLoS Pathog., 12, 2016, e1005894.
54. 54 Gray, R.R., et al. The mode and tempo of hepatitis C virus evolution within and among hosts. BMC Evol. Biol., 11, 2011, 131.
55. 55 Nebbia, G., et al. Hepatitis B infection: current concepts and future challenges. Q. J. Med. 105 (2012), 109–113.
56. 56 Brodin, J., et al. Establishment and stability of the latent HIV-1 DNA reservoir. eLife, 5, 2016, e18889.
57. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5 (1999), 512–517.
58. 58 Crooks, A.M., et al. Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies. J. Infect. Dis. 212 (2015), 1361–1365.
59. + T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. 95 (1998), 8869–8873.
60. 60 Whitney, J.B., et al. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys. Nature 512 (2014), 74–77.
61. + T cells can produce infectious HIV-1 in vivo. Proc. Natl. Acad. Sci. 113 (2016), 1883–1888.
62. 62 Kim, M., Siliciano, R.F., Reservoir expansion by T-cell proliferation may be another barrier to curing HIV infection. Proc. Natl. Acad. Sci. U. S. A., 113, 2016, 201600097.
63. 63 Doekes, H.M.M., et al. Effect of the latent reservoir on the evolution of HIV at the within- and between-host levels. PLoS Comput. Biol., 13, 2017, e1005228.
64. 64 Immonen, T.T., et al. Recombination enhances HIV-1 envelope diversity by facilitating the survival of latent genomic fragments in the plasma virus population. PLoS Comput. Biol. 11 (2015), 1–26.
65. 65 Frenkel, L.M., et al. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. J. Virol. 77 (2003), 5721–5730.
66. 66 Deng, K., et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature 517 (2015), 381–385.
67. 67 Lythgoe, K.A., Fraser, C., New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels. Proc. R. Soc. B 279 (2012), 3367–3375.
68. 68 Immonen, T.T., Leitner, T., Reduced evolutionary rates in HIV-1 reveal extensive latency periods among replicating lineages. Retrovirology, 11, 2014, 81.
69. 69 Scheel, T.K.H., Rice, C.M., Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat. Med. 19 (2013), 837–849.
70. 70 Fletcher, N.F., et al. Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology, 139, 2010 1365–1374.e2.
71. 71 Mee, C.J., et al. Effect of cell polarization on hepatitis C virus entry. J. Virol. 82 (2008), 461–470.
72. 72 Durand, T., et al. Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes. Gut 59 (2010), 934–942.
73. 73 Douam, F., et al. Specialization of hepatitis C virus envelope glycoproteins for B lymphocytes in chronically infected patients. J. Virol. 90 (2015), 992–1008.
74. 74 Ito, M., et al. Peripheral B cells as reservoirs of persistent HCV infection. Front. Microbiol. 2 (2011), 1–3.
75. 75 Watson, J.M., et al. Germline replications and somatic mutation accumulation are independent of vegetative life span in Arabidopsis. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 12226–12231.
76. 76 Keele, B.F., et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 7552–7557.
77. 77 Bull, R.A., et al. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog., 7, 2011, e1002243.
78. 78 Wang, H.-Y., et al. Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases. J. Virol. 84 (2010), 3454–3463.
79. 79 Brown, R.J.P., et al. Hepatitis C Virus envelope glycoprotein fitness defines virus population composition following transmission to a new host. J. Virol. 86 (2012), 11956–11966.
80. 80 Vrancken, B., et al. The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates. PLoS Comput. Biol., 10, 2014, e1003505.
81. 81 Fraser, C., et al. Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Science, 343, 2014, 1243727.
82. 82 Herbeck, J.T., et al. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J. Virol. 80 (2006), 1637–1644.
83. 83 Zanini, F., et al. Population genomics of intrapatient HIV-1 evolution. eLife, 4, 2015, e11282.
84. 84 Lemey, P., et al. Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput. Biol., 3, 2007, e29.
85. 85 Abecasis, A.B., et al. Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution. J. Virol. 83 (2009), 12917–12924.
86. 86 Belshaw, R., et al. Pacing a small cage: mutation and RNA viruses. Trends Ecol. Evol. 23 (2008), 188–193.
87. 87 Rocha, C., et al. Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response. Retrovirology, 10, 2013, 110.
88. 88 Lemey, P., et al. Tracing the origin and history of the HIV-2 epidemic. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 6588–6592.
89. 89 Sagar, M., et al. Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. J. Infect. Dis. 199 (2009), 580–589.
90. 90 Redd, A.D., et al. Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. J. Infect. Dis. 206 (2012), 1433–1442.
91. 91 Stapleton, J.T., et al. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J. Gen. Virol. 92 (2011), 233–246.
92. 92 Berg, M.G., et al. Discovery of a novel human Pegivirus in blood associated with hepatitis C virus co-infection. PLoS Pathog., 11, 2015, e1005325.
93. 93 Plowright, R.K., et al. Transmission or within-host dynamics driving pulses of zoonotic viruses in reservoir host populations. PLoS Negl. Trop. Dis. 10 (2016), 1–21.
94. 94 Otto, S.P., Day, T., A Biologist's Guide to Mathematical Modelling in Ecology and Evolution. 2007, Princeton University Press.
95. 95 Fisher, R.A., The Genetical Theory of Natural Selection. 1930, Clarendon Press.